0
Articles |

Airway Deposition and Clearance and Systemic Pharmacokinetics of Amiloride Following Aerosolization With an Ultrasonic Nebulizer to Normal Airways

Peadar G. Noone; Jeff A. Regnis; Xingrong Liu; Kim L.R. Brouwer; Michael Robinson; Lloyd Edwards; Michael R. Knowles
Author and Funding Information

Affiliations: From the Cystic Fibrosis/Pulmonary Research and Treatment Center, the Division of Pulmonary Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Sydney, Australia,  From the School of Pharmacy, University of North Carolina at Chapel Hill, Sydney, Australia,  From the Royal Prince Alfred Hospital, Sydney, Australia,  From the Department of Biostatistics, University of North Carolina at Chapel Hill, Sydney, Australia

Affiliations: From the Cystic Fibrosis/Pulmonary Research and Treatment Center, the Division of Pulmonary Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Sydney, Australia,  From the School of Pharmacy, University of North Carolina at Chapel Hill, Sydney, Australia,  From the Royal Prince Alfred Hospital, Sydney, Australia,  From the Department of Biostatistics, University of North Carolina at Chapel Hill, Sydney, Australia

Affiliations: From the Cystic Fibrosis/Pulmonary Research and Treatment Center, the Division of Pulmonary Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Sydney, Australia,  From the School of Pharmacy, University of North Carolina at Chapel Hill, Sydney, Australia,  From the Royal Prince Alfred Hospital, Sydney, Australia,  From the Department of Biostatistics, University of North Carolina at Chapel Hill, Sydney, Australia

Affiliations: From the Cystic Fibrosis/Pulmonary Research and Treatment Center, the Division of Pulmonary Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Sydney, Australia,  From the School of Pharmacy, University of North Carolina at Chapel Hill, Sydney, Australia,  From the Royal Prince Alfred Hospital, Sydney, Australia,  From the Department of Biostatistics, University of North Carolina at Chapel Hill, Sydney, Australia


1997 by the American College of Chest Physicians


Chest. 1997;112(5):1283-1290. doi:10.1378/chest.112.5.1283
Text Size: A A A
Published online

Abstract

Study objectives: Airway epithelial ion transport is an important component of the airway defense mechanism, and new therapies that target ion transport are being developed. Amiloride is an example of such a new drug, exerting a dose-dependent action to inhibit Na+ transport. Amiloride may be useful in cystic fibrosis, blocking the characteristic airway epithelial Na+ hyperabsorption that occurs in the disease. To evaluate airway and systemic delivery of amiloride via an ultrasonic nebulizer (Omron NE-UO7), we measured the airway surface concentrations of amiloride in normal volunteers via a novel approach, together with the systemic pharmacokinetics of amiloride.

Design: Direct measurement of airway surface liquid, plasma, and urine amiloride concentrations following ultrasonic nebulization.

Participants/interventions: Seven normal subjects were studied in the General Clinical Research Center of the University of North Carolina. Following inhalation with amiloride (1 mg/mL, 4.5 mL) for approximately 12 min, a bronchoscopy was performed. Amiloride deposition and clearance from airway surfaces over 1 h were evaluated by transbronchoscopic sampling using preweighed filter papers. Pulmonary and systemic absorption was assessed by measuring drug concentrations in blood and urine.

Results: The mean volume aerosolized was 3.5±0.3 mL during 12 min of aerosolization time; the mean initial concentration of amiloride on airway surfaces after nebulization was 1.6x10−4 mol/L, with an elimination half life of approximately 23 min. Peak plasma concentrations of amiloride (30 min, 3.36±0.70 ng/mL) suggest early absorption across lung surfaces, rather than via the GI route. Mean urinary excretion of amiloride over 72 h was 0.63±0.07 mg, with 87% excreted in the first 24 h.

Conclusions: The ultrasonic nebulizer rapidly delivers amiloride to normal conducting airways as assessed by the transbronchoscopic sampling technique. Early blood concentrations of amiloride probably reflect initial absorption across lung surfaces and are a useful index of the efficiency of the machine.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543